Performance analysis of Virax Biolabs Group (VRAX)
Annual Return
Over the past 3 years, VRAX has had an average annual return of -65.70%, underperforming the benchmark SPY, which returned +19.31% annual.
Since Jul 21, 2022, VRAX has had an average annual return of -82.68%, underperforming the benchmark SPY, which returned +18.37% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -52.63% | -84.68% | +55% | -80.05% | -95.99% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -15.79% | -18.75% | -7.69% | -41.67% | +42.86% | -40.00% | +50% | -52.63% | |||||
| 2025 | -25.00% | -1.08% | -31.52% | -14.29% | -1.85% | -16.98% | +2.27% | -26.67% | -0% | -6.06% | -29.03% | -13.64% | -84.68% |
| 2024 | -43.75% | +17.78% | -26.42% | -10.26% | +85.71% | -1.54% | +6.25% | +276.47% | -58.20% | +6.54% | -5.26% | +14.81% | +55% |
| 2023 | +3.74% | -10.10% | +2.14% | -39.79% | -6.52% | -0.47% | +1.87% | -9.63% | -9.14% | -24.58% | -5.19% | -37.50% | -80.05% |
| 2022 | -70.33% | -34.98% | -10.26% | -52.05% | +3.61% | -53.37% | -95.99% |
Drawdown analysis of Virax Biolabs Group (VRAX)
The maximum drawdown for the VRAX was -99.95%, occurring on Apr 10, 2026. This drawdown has not yet recovered.
The current VRAX drawdown is -99.92%.
Since Jul 21, 2022 VRAX has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.95% | Jul 28, 2022 | 928 | Apr 10, 2026 | Ongoing | Ongoing | Ongoing |
| -43.19% | Jul 21, 2022 | 1 | Jul 22, 2022 | 2 | Jul 26, 2022 | 3 |